282 related articles for article (PubMed ID: 15507216)
21. Modulation of insulin release by adenosine A1 receptor agonists and antagonists in INS-1 cells: the possible contribution of 86Rb+ efflux and 45Ca2+ uptake.
Töpfer M; Burbiel CE; Müller CE; Knittel J; Verspohl EJ
Cell Biochem Funct; 2008 Dec; 26(8):833-43. PubMed ID: 18979526
[TBL] [Abstract][Full Text] [Related]
22. Receptors subtypes involved in adenosine-mediated modulation of norepinephrine release from cardiac nerve terminals.
Lorbar M; Chung ES; Nabi A; Skalova K; Fenton RA; Dobson JG; Meyer TE
Can J Physiol Pharmacol; 2004 Nov; 82(11):1026-31. PubMed ID: 15644943
[TBL] [Abstract][Full Text] [Related]
23. Regional differences in the adenosine A(2) receptor-mediated modulation of contractions in rat vas deferens.
Diniz C; Leal S; Gonçalves J
Eur J Pharmacol; 2003 Jan; 460(2-3):191-9. PubMed ID: 12559381
[TBL] [Abstract][Full Text] [Related]
24. [3H]-SCH 58261 labelling of functional A2A adenosine receptors in human neutrophil membranes.
Varani K; Gessi S; Dionisotti S; Ongini E; Borea PA
Br J Pharmacol; 1998 Apr; 123(8):1723-31. PubMed ID: 9605581
[TBL] [Abstract][Full Text] [Related]
25. Facilitation of noradrenaline release by adenosine A(2A) receptors in the epididymal portion and adenosine A(2B) receptors in the prostatic portion of the rat vas deferens.
Queiroz G; Diniz C; Gonçalves J
Eur J Pharmacol; 2002 Jul; 448(1):45-50. PubMed ID: 12126970
[TBL] [Abstract][Full Text] [Related]
26. Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives as adenosine receptor antagonists. Influence of the N5 substituent on the affinity at the human A 3 and A 2B adenosine receptor subtypes: a molecular modeling investigation.
Pastorin G; Da Ros T; Spalluto G; Deflorian F; Moro S; Cacciari B; Baraldi PG; Gessi S; Varani K; Borea PA
J Med Chem; 2003 Sep; 46(20):4287-96. PubMed ID: 13678407
[TBL] [Abstract][Full Text] [Related]
27. Humoral effects of selective adenosine agonists in spontaneously hypertensive rats.
Sala C; Monopoli A; Alberti C; Casati C; Ongini E; Zanchetti A; Morganti A
J Hypertens; 1996 Jan; 14(1):75-9. PubMed ID: 12013498
[TBL] [Abstract][Full Text] [Related]
28. Pharmacological characterisation of the adenosine receptor mediating increased ion transport in the mouse isolated trachea and the effect of allergen challenge.
Kornerup KN; Page CP; Moffatt JD
Br J Pharmacol; 2005 Apr; 144(7):1011-6. PubMed ID: 15685200
[TBL] [Abstract][Full Text] [Related]
29. Cardiovascular pharmacology of the A2A adenosine receptor antagonist, SCH 58261, in the rat.
Monopoli A; Casati C; Lozza G; Forlani A; Ongini E
J Pharmacol Exp Ther; 1998 Apr; 285(1):9-15. PubMed ID: 9535988
[TBL] [Abstract][Full Text] [Related]
30. Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists.
Baraldi PG; Tabrizi MA; Preti D; Bovero A; Romagnoli R; Fruttarolo F; Zaid NA; Moorman AR; Varani K; Gessi S; Merighi S; Borea PA
J Med Chem; 2004 Mar; 47(6):1434-47. PubMed ID: 14998332
[TBL] [Abstract][Full Text] [Related]
31. Repeated treatment with adenosine A1 receptor agonist and antagonist modifies the anticonvulsant properties of CPPene.
De Sarro G; Donato Di Paola E; Falconi U; Ferreri G; De Sarro A
Eur J Pharmacol; 1996 Dec; 317(2-3):239-45. PubMed ID: 8997606
[TBL] [Abstract][Full Text] [Related]
32. Repeated administration of selective adenosine A1 and A2 receptor agonists in the spontaneously hypertensive rat: tolerance develops to A1-mediated hemodynamic effects.
Casati C; Monopoli A; Dionisotti S; Zocchi C; Bonizzoni E; Ongini E
J Pharmacol Exp Ther; 1994 Mar; 268(3):1506-11. PubMed ID: 8138961
[TBL] [Abstract][Full Text] [Related]
33. Cocaine-induced hyperactivity is more influenced by adenosine receptor agonists than amphetamine-induced hyperactivity.
Poleszak E; Malec D
Pol J Pharmacol; 2002; 54(4):359-66. PubMed ID: 12523489
[TBL] [Abstract][Full Text] [Related]
34. ZM241385 is an antagonist of the facilitatory responses produced by the A2A adenosine receptor agonists CGS21680 and HENECA in the rat hippocampus.
Cunha RA; Constantino MD; Ribeiro JA
Br J Pharmacol; 1997 Dec; 122(7):1279-84. PubMed ID: 9421273
[TBL] [Abstract][Full Text] [Related]
35. A1 and A2A adenosine receptor modulation of alpha 1-adrenoceptor-mediated contractility in human cultured prostatic stromal cells.
Preston A; Frydenberg M; Haynes JM
Br J Pharmacol; 2004 Jan; 141(2):302-10. PubMed ID: 14751869
[TBL] [Abstract][Full Text] [Related]
36. Mouse cerebellar GABAB participation in the expression of acute ethanol-induced ataxia and in its modulation by the cerebellar adenosinergic A1 system.
Dar MS
Brain Res Bull; 1996; 41(1):53-9. PubMed ID: 8883916
[TBL] [Abstract][Full Text] [Related]
37. Characterization of adenosine receptors in the human bladder carcinoma T24 cell line.
Phelps PT; Anthes JC; Correll CC
Eur J Pharmacol; 2006 Apr; 536(1-2):28-37. PubMed ID: 16581066
[TBL] [Abstract][Full Text] [Related]
38. Adenosine A1 receptor-mediated inhibition of dopamine release from rat striatal slices is modulated by D1 dopamine receptors.
O'Neill C; Nolan BJ; Macari A; O'Boyle KM; O'Connor JJ
Eur J Neurosci; 2007 Dec; 26(12):3421-8. PubMed ID: 18052983
[TBL] [Abstract][Full Text] [Related]
39. P2-purinoceptor-mediated inhibition of noradrenaline release in rat atria.
von Kügelgen I; Stoffel D; Starke K
Br J Pharmacol; 1995 May; 115(2):247-54. PubMed ID: 7670726
[TBL] [Abstract][Full Text] [Related]
40. Molecular identification and pharmacological characterization of adenosine receptors in the guinea-pig colon.
Kadowaki M; Takeda M; Tokita K; Hanaoka K; Tomoi M
Br J Pharmacol; 2000 Mar; 129(5):871-6. PubMed ID: 10696084
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
